A new study from Cincinnati’s Children’s Hospital has found that the use of a wearable cardioverter defibrillator (WCD) is safe and effective for treating ventricular arrhythmias in pediatric patients at risk from sudden cardiac death.

iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care solutions company focused on the advancement of cardiac care, announced the recent publication of two documents in support of extended continuous ambulatory monitoring for arrhythmia detection.

Pasadena, California-based Geneva Health Solutions has raised $1.9 million to expand the reach of its cardiac monitoring device, a gadget aimed to remotely help manage patients with implanted cardiac devices.

Geneva Health Solutions (formerly Geneva Healthcare) announced it raised $1.9 million to expand its Cardiac Remote Monitoring Solutions business to cardiology providers to help manage patients with implanted cardiac devices beyond the walls of the practice.

Professor William Wijns, co-director of EuroPCR and chairman of PCR, has joined NUI Galway as a professor of medical devices. He will head the $5 million research project to develop wearable sensors for patients at high risk of heart attacks.

In May 2015, the Heart Rhythm Society released a consensus statement recommending that remote monitoring become the standard of care for patients with cardiovascular implantable electronic devices. The panel argued that remote monitoring helped check the devices’ electronic integrity and functionality and improved patient adherence.

(PresseBox) BIOTRONIK Home Monitoring® received strong endorsements during the Cardiostim scientific session “Improving Patient Outcomes in Arrhythmia Management.” 

Medtronic plc (NYSE: MDT) today announced U.S. Food and Drug Administration (FDA) approval and U.S. commercial availability of the MyCareLink Smart(TM) Monitor, the world's first app-based remote monitoring system for patients with implantable pacemakers.